Welcome to LookChem.com Sign In|Join Free

CAS

  • or

530-59-6

Post Buying Request

530-59-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

530-59-6 Usage

Chemical Properties

yellow-brown crystalline powder

Uses

Different sources of media describe the Uses of 530-59-6 differently. You can refer to the following data:
1. 4-Hydroxy-3,5-dimethoxycinnamic acid is a commonly used matrix in MALDI mass spectrometry. It is a useful matrix for a wide variety of peptides and proteins. It serves well as a matrix for MALDI due to its ability to absorb laser radiation and to also donate protons (H+) to the analyte of interest.
2. Sinapic acid was suitable as phenolic standard for HPLC analysis in determination of Sinapic acid derivatives in Canola extracts. 10 g/L of sinapinic acid with solvent was suitable as matrix for ultraviolet laser desorption mass spectrometric determination of proteins. It was also suitable to use as matrix for MALDI-TOFMS and MALDI-ion mobility-TOFMS to determine phospholipids in tissue.

Definition

ChEBI: A monohydroxycinnamic acid that is cinnamic acid in which the phenyl hydrogens at positions 3, 4, and 5 are replaced by methoxy, hydroxy, and methoxy groups, respectively.

General Description

Sinapic acid is an hydroxycinnamic acid derivative that occurs naturally in Brassicaceae species.

Biochem/physiol Actions

On removal of amino group from phenylalanine, catalysing with enzyme phenylalanine ammonia-lyase forms cinnamic acid. The precursor of hydroxycinnamates is produced after hydroxylation of benzene ring. One of the precursors produced is sinapic acid. Sinapic acid exhibits antimicrobial, antioxidant, anticancer, anti-inflammatory, and anti-anxiety activity. Sinapine (sinapoyl choline) has been acknowledged as an acetylcholinesterase inhibitor, making it therapeutically applicable in treatment of various diseases. 4-Vinylsyringol (a decarboxylation product of sinapic acid) is a potent antimutagenic and antioxidative agent, involved in suppressing the induction of inflammatory cytokines and carcinogenesis. Owing to their anti-oxidative activity, these compounds have been considered to be potentially employed in the pharmaceutical industry, cosmetics and food processing.

Purification Methods

Crystallise it from water. [Beilstein 10 H 508, 10 IV 2104.]

Check Digit Verification of cas no

The CAS Registry Mumber 530-59-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,3 and 0 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 530-59:
(5*5)+(4*3)+(3*0)+(2*5)+(1*9)=56
56 % 10 = 6
So 530-59-6 is a valid CAS Registry Number.
InChI:InChI=1/C11H12O5/c1-15-8-5-7(3-4-10(12)13)6-9(16-2)11(8)14/h3-6,14H,1-2H3,(H,12,13)/p-1/b4-3+

530-59-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D1765)  3,5-Dimethoxy-4-hydroxycinnamic Acid  >98.0%(GC)(T)

  • 530-59-6

  • 5g

  • 720.00CNY

  • Detail
  • TCI America

  • (D1765)  3,5-Dimethoxy-4-hydroxycinnamic Acid  >98.0%(GC)(T)

  • 530-59-6

  • 25g

  • 2,370.00CNY

  • Detail
  • Alfa Aesar

  • (A15676)  4-Hydroxy-3,5-dimethoxycinnamic acid, 98%   

  • 530-59-6

  • 1g

  • 248.0CNY

  • Detail
  • Alfa Aesar

  • (A15676)  4-Hydroxy-3,5-dimethoxycinnamic acid, 98%   

  • 530-59-6

  • 5g

  • 903.0CNY

  • Detail
  • Alfa Aesar

  • (A15676)  4-Hydroxy-3,5-dimethoxycinnamic acid, 98%   

  • 530-59-6

  • 25g

  • 3599.0CNY

  • Detail
  • Sigma-Aldrich

  • (49508)  Sinapicacid  Ultra pure, matrix substance for MALDI-MS, ≥99.5%

  • 530-59-6

  • 49508-10X10MG-F

  • 2,449.98CNY

  • Detail
  • Sigma-Aldrich

  • (85429)  Sinapicacid  matrix substance for MALDI-MS, ≥99.0% (T)

  • 530-59-6

  • 85429-1G

  • 669.24CNY

  • Detail
  • Sigma-Aldrich

  • (85429)  Sinapicacid  matrix substance for MALDI-MS, ≥99.0% (T)

  • 530-59-6

  • 85429-5G

  • 1,166.49CNY

  • Detail

530-59-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name trans-sinapic acid

1.2 Other means of identification

Product number -
Other names Sinapinic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Food additives -> Flavoring Agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:530-59-6 SDS

530-59-6Synthetic route

C19H30O6

C19H30O6

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With potassium tert-butylate In isopropyl alcohol at 120℃; for 24h;94%
malonic acid
141-82-2

malonic acid

syringic aldehyde
134-96-3

syringic aldehyde

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With aniline In pyridine at 60℃; Darkness;85%
Stage #1: malonic acid; syringic aldehyde With piperazine; pyridine; p-toluidine In toluene at 80℃; for 3h;
Stage #2: With potassium carbonate In water; toluene at 20℃; for 0.166667h;
83.7%
With piperidine; pyridine
3-methyl-4-nitro-5-<2-(3,5-dimethoxy-4-hydroxyphenyl)ethenyl>isoxazole
85364-71-2

3-methyl-4-nitro-5-<2-(3,5-dimethoxy-4-hydroxyphenyl)ethenyl>isoxazole

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With sodium hydroxide for 2h; Heating;72.9%
ethyl-(4'-acetoxy-3',5'-dimethoxyphenyl)-prop-2-enoate
110233-74-4

ethyl-(4'-acetoxy-3',5'-dimethoxyphenyl)-prop-2-enoate

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With potassium hydroxide In water Heating;
alatanin 1
131189-50-9

alatanin 1

A

cyanidin 3-O-gentiobioside
47845-44-3

cyanidin 3-O-gentiobioside

B

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With hydrogenchloride at 60℃; for 24h;
O-sinapoylcholine

O-sinapoylcholine

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With sodium hydroxide Heating;
quercetin 3-<6-sinapyl-β-D-glucopyranosyl(1->2)-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside>

quercetin 3-<6-sinapyl-β-D-glucopyranosyl(1->2)-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside>

A

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

B

5,7-dihydroxy-3-[β-D-glucopyranosyl-(1->2)-β-D-glucopyranosyl-(1->2)-β-D-glucopyranosyl]-2-(3,4-dihydroxyphenyl)-4H-1-benzopyran-4-one
38681-85-5

5,7-dihydroxy-3-[β-D-glucopyranosyl-(1->2)-β-D-glucopyranosyl-(1->2)-β-D-glucopyranosyl]-2-(3,4-dihydroxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With sodium hydroxide In sodium hydroxide for 24h; Product distribution; Ambient temperature; other reagent;
trimethyl-<2-(4-hydroxy-3.5-dimethoxy-trans-cinnamoyloxy)-ethyl>-ammonium iodide

trimethyl-<2-(4-hydroxy-3.5-dimethoxy-trans-cinnamoyloxy)-ethyl>-ammonium iodide

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With potassium hydroxide
6'''-sinapoylsaponarin

6'''-sinapoylsaponarin

A

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

B

saponarin

saponarin

Conditions
ConditionsYield
With sodium hydroxide In methanol; water at 60℃; for 4h;
4-acetoxy-3,5-dimethoxybenzaldehyde
53669-33-3

4-acetoxy-3,5-dimethoxybenzaldehyde

sodium acetate
127-09-3

sodium acetate

acetic anhydride
108-24-7

acetic anhydride

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
Stage #1: 4-acetoxy-3,5-dimethoxybenzaldehyde; sodium acetate; acetic anhydride at 145 - 150℃; for 12h; Perkin Reaction;
Stage #2: With sodium hydroxide; water
Stage #3: With hydrogenchloride In water pH=3; Product distribution / selectivity;
syringic aldehyde
134-96-3

syringic aldehyde

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 37.6 percent / piperidine
2: 72.9 percent / 1 N aq. NaOH / 2 h / Heating
View Scheme
trans-p-sinapoyl β-D-glucopyranoside
78185-48-5

trans-p-sinapoyl β-D-glucopyranoside

A

sinapoyl-L-malate

sinapoyl-L-malate

B

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
1-O-sinapoyl-β-glucose:L-malate sinapoyltransferase In dimethyl sulfoxide at 30℃; pH=6.0;
trans-p-sinapoyl β-D-glucopyranoside
78185-48-5

trans-p-sinapoyl β-D-glucopyranoside

A

sinapoyl-L-malate

sinapoyl-L-malate

B

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

C

1(E),2(E)-di-O-sinapoyl β-D-glucopyranoside

1(E),2(E)-di-O-sinapoyl β-D-glucopyranoside

Conditions
ConditionsYield
1-O-sinapoyl-β-glucose:L-malate sinapoyltransferase In dimethyl sulfoxide at 30℃; pH=8.0;
trans-p-sinapoyl β-D-glucopyranoside
78185-48-5

trans-p-sinapoyl β-D-glucopyranoside

A

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

B

1(E),2(E)-di-O-sinapoyl β-D-glucopyranoside

1(E),2(E)-di-O-sinapoyl β-D-glucopyranoside

Conditions
ConditionsYield
1-O-sinapoyl-β-glucose:L-malate sinapoyltransferase In dimethyl sulfoxide at 30℃; pH=6.0;
(8R,7'S,8'R)-5,5'-dimethoxylariciresinol 9'-O-β-D-(6-O-E-4-hydroxy-3,5-dimethoxycinnamoyl)glucopyranoside
1062606-23-8

(8R,7'S,8'R)-5,5'-dimethoxylariciresinol 9'-O-β-D-(6-O-E-4-hydroxy-3,5-dimethoxycinnamoyl)glucopyranoside

A

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

B

(7S,8R,8’R)-4,9,4’-trihydroxy-3,5,3’,5’-tetramethoxy-7,9’-epoxylignan 9-O-β-D-glucopyranoside

(7S,8R,8’R)-4,9,4’-trihydroxy-3,5,3’,5’-tetramethoxy-7,9’-epoxylignan 9-O-β-D-glucopyranoside

Conditions
ConditionsYield
With sodium hydroxide; water at 20℃; for 1h; Inert atmosphere;
3-α-trans-sinapoyloxyjhanol 18-O-β-D-glucopyranoside
1276682-51-9

3-α-trans-sinapoyloxyjhanol 18-O-β-D-glucopyranoside

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With methanol; potassium hydroxide for 5h; Reflux;
Organosolv-beech-lignin

Organosolv-beech-lignin

A

1,3-dimethoxy-2-hydroxy-benzene
91-10-1

1,3-dimethoxy-2-hydroxy-benzene

B

2,6-dimethoxy-p-quinone
530-55-2

2,6-dimethoxy-p-quinone

C

3-methoxy-4-hydroxybenzoic acid
121-34-6

3-methoxy-4-hydroxybenzoic acid

D

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

E

vanillin
121-33-5

vanillin

F

syringic aldehyde
134-96-3

syringic aldehyde

Conditions
ConditionsYield
With manganese(II) nitrate at 100℃; under 6000.6 Torr; Ionic liquid; Autoclave;
4-O-[(E)-4-hydroxy-3,5-dimethoxycinnamoyl]bergenin
1359001-20-9

4-O-[(E)-4-hydroxy-3,5-dimethoxycinnamoyl]bergenin

A

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

B

methyl 3,4,5-trimethoxycinnamate
20329-96-8

methyl 3,4,5-trimethoxycinnamate

Conditions
ConditionsYield
Stage #1: 4-O-[(E)-4-hydroxy-3,5-dimethoxycinnamoyl]bergenin With trifluoroacetic acid In water for 40h; Reflux;
Stage #2: diazomethane In diethyl ether at 4℃; for 3h;
peonidin 3-O-[2-O-(2-O-(trans-sinapoyl)-glucosyl)-6-O-(trans-p-coumaroyl)-glucoside]-5-O-[6-O-(malonyl)-glucoside]

peonidin 3-O-[2-O-(2-O-(trans-sinapoyl)-glucosyl)-6-O-(trans-p-coumaroyl)-glucoside]-5-O-[6-O-(malonyl)-glucoside]

A

D-Glucose
2280-44-6

D-Glucose

B

malonic acid
141-82-2

malonic acid

C

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

D

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

E

peonidin chloride
134-01-0

peonidin chloride

Conditions
ConditionsYield
With hydrogenchloride; water at 100℃; for 1h;
canolol
28343-22-8

canolol

potassium hydrogencarbonate
298-14-6

potassium hydrogencarbonate

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With phenolic acid decarboxylase from Pantoea sp. In aq. phosphate buffer; acetonitrile at 30℃; for 24h; pH=8.5; Reagent/catalyst; Sealed tube; Enzymatic reaction;
C17H22O10

C17H22O10

A

D-glucose
50-99-7

D-glucose

B

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
With water; trifluoroacetic acid
oxypetalumoside I

oxypetalumoside I

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Conditions
ConditionsYield
Alkaline conditions;
methanol
67-56-1

methanol

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

methyl (E)-sinapate
42041-51-0

methyl (E)-sinapate

Conditions
ConditionsYield
With sulfuric acid for 24h; Reflux;100%
With sulfuric acid Reflux;100%
With sulfuric acid for 6h; Reflux;100%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

trans-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-6,8-dimethoxy-1,2-dihydronaphthalene-2,3-dicarboxylic acid
26350-60-7, 52802-10-5

trans-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-6,8-dimethoxy-1,2-dihydronaphthalene-2,3-dicarboxylic acid

Conditions
ConditionsYield
With oxygen In water for 24h; var. pH; also with var. antioxidants;100%
With air In water
With air; phosphate-boric acid buffer at 22℃; pH=7; Kinetics; Further Variations:; pH-values; Reagents; Oxidation;
Multi-step reaction with 3 steps
1: AcCl / 16 h
2: 52 percent / aq. FeCl3 / methanol / 48 h
3: 60 percent / aq. NaOH / 16 h / 20 °C
View Scheme
N-hydroxyurea
127-07-1

N-hydroxyurea

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

1-hydroxy-1-((E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acryloyl)urea

1-hydroxy-1-((E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acryloyl)urea

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 2.5h; Inert atmosphere;100%
ethanol
64-17-5

ethanol

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

ethyl (2E)-3-[4-hydroxy-3,5-bis(methyloxy)phenyl]-2-propenoate
41628-47-1

ethyl (2E)-3-[4-hydroxy-3,5-bis(methyloxy)phenyl]-2-propenoate

Conditions
ConditionsYield
With acetyl chloride for 12h;98%
With sulfuric acid at 100℃; for 5.5h;93.6%
With hydrogenchloride In water Reflux;83%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

dihydrosinapic acid
14897-78-0

dihydrosinapic acid

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol at 25℃; under 2585.81 Torr;94%
With sodium hydroxide anschliessend Behandeln mit einer Nickel-Aluminium-Legierung;
With ethanol; nickel at 110℃; under 110326 Torr; Hydrogenation;
With hydrogen; palladium on activated charcoal for 3h;
With hydrogen; 5%-palladium/activated carbon In ethanol at 120℃; under 76005.1 Torr; for 5h;
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

acetic anhydride
108-24-7

acetic anhydride

(E)-4-acetoxy-3,5-dimethoxycinnamic acid
90985-68-5, 113158-15-9

(E)-4-acetoxy-3,5-dimethoxycinnamic acid

Conditions
ConditionsYield
With pyridine at 20℃; for 3h;94%
With pyridine at 20℃;70%
With pyridine at 100℃; for 3h;
ethyl 2-[N-methyl-N-(octyloxyacetyl)amino]-4-aminobenzoate
229026-06-6

ethyl 2-[N-methyl-N-(octyloxyacetyl)amino]-4-aminobenzoate

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

ethyl 2-[N-methyl-N-(octyloxyacetyl)amino]-4-[(3,5-dimethoxy-4-hydroxycinnamoyl)amino]-benzoate

ethyl 2-[N-methyl-N-(octyloxyacetyl)amino]-4-[(3,5-dimethoxy-4-hydroxycinnamoyl)amino]-benzoate

Conditions
ConditionsYield
With pyridine In tetrahydrofuran; water; N,N-dimethyl-formamide; toluene94%
1-octadecanol
112-92-5

1-octadecanol

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

trans-octadecyl 3-(3,5-dimethoxy-4-hydroxyphenyl)propenoate
1173709-52-8

trans-octadecyl 3-(3,5-dimethoxy-4-hydroxyphenyl)propenoate

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 20℃; Mitsunobu reaction;90%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

dimethyl (2S,2E)-2-((3-(4-hydroxy-3,5-dimethoxyphenyl)acryloyl)oxy)succinate
1270043-91-8

dimethyl (2S,2E)-2-((3-(4-hydroxy-3,5-dimethoxyphenyl)acryloyl)oxy)succinate

Conditions
ConditionsYield
Stage #1: trans-3,5-dimethoxy-4-hydroxycinnamic acid With 1H-imidazole In N,N-dimethyl-formamide
Stage #2: tert-butyldimethylsilyl chloride In N,N-dimethyl-formamide at 0℃; for 1h;
Stage #3: With potassium carbonate In tetrahydrofuran; methanol; water
86%
Stage #1: trans-3,5-dimethoxy-4-hydroxycinnamic acid; tert-butyldimethylsilyl chloride With 1H-imidazole In N,N-dimethyl-formamide at 0 - 20℃; for 4h;
Stage #2: With potassium carbonate In methanol; water at 20℃; for 0.5h;
72.9%
p-hydroxyphenethyl alcohol
501-94-0

p-hydroxyphenethyl alcohol

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

Tyrosol synapate
1428533-02-1

Tyrosol synapate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 48h; Mitsunobu Displacement; chemoselective reaction;85%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-(methylthio)benzenesulfonamide

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-(methylthio)benzenesulfonamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylthio)phenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylthio)phenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide

Conditions
ConditionsYield
Stage #1: trans-3,5-dimethoxy-4-hydroxycinnamic acid; N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-(methylthio)benzenesulfonamide With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 25℃; for 1.16667h; Inert atmosphere;
Stage #2: With dmap In N,N-dimethyl-formamide at 25℃; for 2h; Inert atmosphere;
85%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-4-methoxy-N-propylbenzenesulfonamide

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-4-methoxy-N-propylbenzenesulfonamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((4-methoxy-N-propylphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((4-methoxy-N-propylphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide

Conditions
ConditionsYield
Stage #1: trans-3,5-dimethoxy-4-hydroxycinnamic acid; N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-4-methoxy-N-propylbenzenesulfonamide With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 25℃; for 1.16667h; Inert atmosphere;
Stage #2: With dmap In N,N-dimethyl-formamide at 25℃; for 2h; Inert atmosphere;
84%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

sunitinib
557795-19-4

sunitinib

sunitinib sinapinate

sunitinib sinapinate

Conditions
ConditionsYield
In methanol at 25 - 35℃; for 0.25h;83%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-methoxybenzenesulfonamide
159005-71-7

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-methoxybenzenesulfonamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide

Conditions
ConditionsYield
Stage #1: trans-3,5-dimethoxy-4-hydroxycinnamic acid; N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-methoxybenzenesulfonamide With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 25℃; for 1.16667h; Inert atmosphere;
Stage #2: With dmap In N,N-dimethyl-formamide at 25℃; for 2h; Inert atmosphere;
83%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-6-methoxypyridine-3-sulfonamide

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-6-methoxypyridine-3-sulfonamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-6-methoxypyridine)-3-sulfonamido)-1-phenylbutan-2-yl)acrylamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-6-methoxypyridine)-3-sulfonamido)-1-phenylbutan-2-yl)acrylamide

Conditions
ConditionsYield
Stage #1: trans-3,5-dimethoxy-4-hydroxycinnamic acid; N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-6-methoxypyridine-3-sulfonamide With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 25℃; for 1.16667h; Inert atmosphere;
Stage #2: With dmap In N,N-dimethyl-formamide at 25℃; for 2h; Inert atmosphere;
82%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

4-(2-aminoethyl)-1-(phenylmethyl)piperidine
86945-25-7

4-(2-aminoethyl)-1-(phenylmethyl)piperidine

(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylamide

(E)-N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 12h;80%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

2,5-Dihydroxyacetophenone
490-78-8

2,5-Dihydroxyacetophenone

(E)-2-acetyl-4-hydroxyphenyl 3-(4-hydroxy-3,5-dimethoxyphenyl)acrylate

(E)-2-acetyl-4-hydroxyphenyl 3-(4-hydroxy-3,5-dimethoxyphenyl)acrylate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 48h; Mitsunobu Displacement; chemoselective reaction;80%
2-(acetylamino)ethanethiol
1190-73-4

2-(acetylamino)ethanethiol

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

3-(4-hydroxy-3,5-dimethoxy-phenyl)-thioacrylic acid S-(2-acetylamino-ethyl) ester

3-(4-hydroxy-3,5-dimethoxy-phenyl)-thioacrylic acid S-(2-acetylamino-ethyl) ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h;79%
tert-butylisonitrile
119072-55-8, 7188-38-7

tert-butylisonitrile

2-bromobenzylamine
3959-05-5

2-bromobenzylamine

2-benzoyloxyacetaldehyde
64904-47-8

2-benzoyloxyacetaldehyde

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

2-{(2-bromobenzyl)[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]amino}-3-(tert-butylamino)-3-oxopropyl benzoate

2-{(2-bromobenzyl)[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]amino}-3-(tert-butylamino)-3-oxopropyl benzoate

Conditions
ConditionsYield
Stage #1: 2-bromobenzylamine; 2-benzoyloxyacetaldehyde With hydrogenchloride; triethylamine In methanol at 20℃; for 1h; Ugi Condensation; Inert atmosphere;
Stage #2: tert-butylisonitrile; trans-3,5-dimethoxy-4-hydroxycinnamic acid In methanol at 20℃; for 48h; Ugi Condensation; Inert atmosphere;
79%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isopropyl-4-methoxybenzenesulfonamide

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isopropyl-4-methoxybenzenesulfonamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isopropyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide

(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isopropyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide

Conditions
ConditionsYield
Stage #1: trans-3,5-dimethoxy-4-hydroxycinnamic acid; N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isopropyl-4-methoxybenzenesulfonamide With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 25℃; for 1.16667h; Inert atmosphere;
Stage #2: With dmap In N,N-dimethyl-formamide at 25℃; for 2h; Inert atmosphere;
79%
tert-butylisonitrile
119072-55-8, 7188-38-7

tert-butylisonitrile

2-benzoyloxyacetaldehyde
64904-47-8

2-benzoyloxyacetaldehyde

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

(2-bromo-4,5-dimethoxyphenyl)methanamine
89525-51-9

(2-bromo-4,5-dimethoxyphenyl)methanamine

2-{(2-bromo-4,5-dimethoxybenzyl)[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]amino}-3-(tert-butylamino)-3-oxopropyl benzoate

2-{(2-bromo-4,5-dimethoxybenzyl)[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]amino}-3-(tert-butylamino)-3-oxopropyl benzoate

Conditions
ConditionsYield
Stage #1: 2-benzoyloxyacetaldehyde; (2-bromo-4,5-dimethoxyphenyl)methanamine With hydrogenchloride; triethylamine In methanol at 20℃; for 1h; Ugi Condensation; Inert atmosphere;
Stage #2: tert-butylisonitrile; trans-3,5-dimethoxy-4-hydroxycinnamic acid In methanol at 20℃; for 48h; Ugi Condensation; Inert atmosphere;
78%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-cyclopropyl-4-methoxybenzenesulfonamide

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-cyclopropyl-4-methoxybenzenesulfonamide

(E)-N-((2S,3R)-4-((N-cyclopropyl-4-methoxyphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylamide

(E)-N-((2S,3R)-4-((N-cyclopropyl-4-methoxyphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylamide

Conditions
ConditionsYield
Stage #1: trans-3,5-dimethoxy-4-hydroxycinnamic acid; N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-cyclopropyl-4-methoxybenzenesulfonamide With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 25℃; for 1.16667h; Inert atmosphere;
Stage #2: With dmap In N,N-dimethyl-formamide at 25℃; for 2h; Inert atmosphere;
78%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

thiophenol
108-98-5

thiophenol

-3 thiopropene-2 oate de S-phenyle
56254-03-6

-3 thiopropene-2 oate de S-phenyle

Conditions
ConditionsYield
With fluoro-2 methyl-1 pyridinium; triethylamine In dichloromethane at -20℃; for 2h;77%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

benzyl bromide
100-39-0

benzyl bromide

(E)-8-(4-Benzyloxy-3,5-dimethoxystyryl)-1,3-dipropylxanthine

(E)-8-(4-Benzyloxy-3,5-dimethoxystyryl)-1,3-dipropylxanthine

Conditions
ConditionsYield
With sodium hydroxide; sodium chloride; potassium carbonate In N-methyl-acetamide; ethanol; water77%
With sodium hydroxide; sodium chloride; potassium carbonate In N-methyl-acetamide; ethanol; water77%
Cyclohexyl isocyanide
931-53-3

Cyclohexyl isocyanide

2-bromobenzylamine
3959-05-5

2-bromobenzylamine

2-benzoyloxyacetaldehyde
64904-47-8

2-benzoyloxyacetaldehyde

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

2-{(2-bromobenzyl)[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]amino}-3-(cyclohexylamino)-3-oxopropyl benzoate

2-{(2-bromobenzyl)[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]amino}-3-(cyclohexylamino)-3-oxopropyl benzoate

Conditions
ConditionsYield
Stage #1: 2-bromobenzylamine; 2-benzoyloxyacetaldehyde With hydrogenchloride; triethylamine In methanol at 20℃; for 1h; Ugi Condensation; Inert atmosphere;
Stage #2: Cyclohexyl isocyanide; trans-3,5-dimethoxy-4-hydroxycinnamic acid In methanol at 20℃; for 48h; Ugi Condensation; Inert atmosphere;
76%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

3-(3,4-dimethylphenyl)propylamine
142332-70-5

3-(3,4-dimethylphenyl)propylamine

3-(3,5-dimethoxy-4-hydroxyphenyl)-N-[3-(3,4-dimethylphenyl)propyl]acrylamide

3-(3,5-dimethoxy-4-hydroxyphenyl)-N-[3-(3,4-dimethylphenyl)propyl]acrylamide

Conditions
ConditionsYield
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In acetonitrile at 0 - 20℃;75%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

A

syringic aldehyde
134-96-3

syringic aldehyde

B

3,6-dihydroxy-2,4-dimethoxy-7H-benzocyclohepten-7-one

3,6-dihydroxy-2,4-dimethoxy-7H-benzocyclohepten-7-one

Conditions
ConditionsYield
With Ankistrodesmus braunii C202.7a Microbiological reaction;A 5%
B 75%
trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

2,6-bis(4'-hydroxy-3',5'-dimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane-4,8-dione
41514-36-7, 63324-54-9, 63427-87-2, 65167-29-5

2,6-bis(4'-hydroxy-3',5'-dimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane-4,8-dione

Conditions
ConditionsYield
With iron(III) chloride In ethanol at 20℃; for 1h;75%

530-59-6Relevant articles and documents

Activities of Arabidopsis sinapoylglucose:malate sinapoyltransferase shed light on functional diversification of serine carboxypeptidase-like acyltransferases

Stehle, Felix,Brandt, Wolfgang,Schmidt, Juergen,Milkowski, Carsten,Strack, Dieter

, p. 1826 - 1831 (2008)

Analysis of the catalytic properties of the serine carboxypeptidase-like (SCPL) 1-O-sinapoyl-β-glucose:l-malate sinapoyltransferase (SMT) from Arabidopsis showed that the enzyme exhibits besides its primary sinapoylation of l-malate, minor hydrolytic and disproportionation activities, producing free sinapic acid and 1,2-di-O-sinapoyl-β-glucose, respectively. The ability of the enzyme to liberate sinapic acid from the donor molecule 1-O-sinapoyl-β-glucose indicates the existence of a short-lived acylenzyme intermediate in the proposed random sequential bi-bi mechanism of catalysis. SMT-catalyzed formation of disinapoylglucose has been corroborated by docking studies with an established homology structure model that illustrates the possible binding of two 1-O-sinapoyl-β-glucose molecules in the active site and the intermolecular reaction of the two glucose esters. The SMT gene is embedded in a tandem cluster of five SCPL sinapoyltransferase genes, which encode enzymes with high amino acid sequence identities and partially overlapping substrate specificities. We assume that in recent duplications of genes encoding SCPL proteins, neofunctionalization of the duplicates to accept 1-O-sinapoyl-β-glucose as acyl donor was gained first, followed by subfunctionalization leading to different acyl acceptor specificities.

Noda,Matsumoto

, p. 131 (1971)

Dependency of the hydrogen bonding capacity of the solvent anion on the thermal stability of feruloyl esterases in ionic liquid systems

Zeuner, Birgitte,Stahlberg, Tim,Van Buu, Olivier Nguyen,Kunov-Kruse, Andreas Jonas,Riisager, Anders,Meyer, Anne S.

, p. 1550 - 1557 (2011)

Three feruloyl esterases, EC 3.1.1.73, (FAEs), namely FAE A from Aspergillus niger (AnFaeA), FAE C from Aspergillus nidulans (AndFaeC), and the FAE activity in a commercial β-glucanase mixture from Humicola insolens (Ultraflo L) were tested for their ability to catalyse esterification of sinapic acid with glycerol in four ionic liquid (IL) systems. The IL systems were systematically composed of two selected pairs of cations and anions, respectively: [BMIm][PF6], [C2OHMIm][PF6], [BMIm][BF4], and [C2OHMIm][BF4]. AnFaeA had activity in [PF6]--based ILs, whereas the AndFaeC and the FAE in Ultraflo L had no appreciable activities and were generally unstable in the IL systems. FAE stability in the IL systems was apparently highly dependent on enzyme structure, and notably AnFaeA's similarity to IL-compatible lipases may explain its stability. The thermal stability of AnFaeA was higher in buffer than in the IL systems, but at 40 °C and below there was no significant difference in AnFaeA stability between the buffer and the [PF6] --based systems: AnFaeA was stable in the [BMIm][PF6] and [C2OHMIm][PF6] systems for 2 h at 40 °C. However, the IL anion had a major effect on stability: [BF4]- caused rapid inactivation of AnFaeA, while [PF6]- did not. The cation did not have a similar effect. These observations could be explained in terms of the hydrogen bonding capacity of IL cations and anions via COSMO-RS simulations.

Total Syntheses and Anti-inflammatory Activities of Syringin and Its Natural Analogues

Dong, Hongbo,Du, Weihong,He, Yujiao,Shi, Zheng,Wang, Yingying,Wu, Min

supporting information, p. 2866 - 2874 (2021/11/12)

Syringin (1), a natural bioactive glucoside isolated from the root of Acanthopanax senticosus (Rupr. Maxim.) Harms, possesses significant anti-inflammatory activity. In this study, we have accomplished the total syntheses of syringin (1), along with its natural analogues 2-12, from a common starting material, syringaldehyde (13), in 4-8 steps with an overall yields of 11.8-61.3%. The anti-inflammatory activities of these compounds were determined against NO production in the LPS-stimulated RAW264.7 cells. Among them, compounds 1-5, 7, and 9 exhibited different levels of anti-inflammatory activity.

Dual Nickel/Ruthenium Strategy for Photoinduced Decarboxylative Cross-Coupling of α,β-Unsaturated Carboxylic Acids with Cycloketone Oxime Esters

Gao, Ang,Jiang, Run-Chuang,Liu, Chuang-Chuang,Liu, Qi-Le,Lu, Xiao-Yu,Xia, Ze-Jie

supporting information, p. 8829 - 8842 (2021/06/30)

Herein, a dual nickel/ruthenium strategy is developed for photoinduced decarboxylative cross-coupling between α,β-unsaturated carboxylic acids and cycloketone oxime esters. The reaction mechanism is distinct from previous photoinduced decarboxylation of α,β-unsaturated carboxylic acids. This reaction might proceed through a nickelacyclopropane intermediate. The C(sp2)-C(sp3) bond constructed by the aforementioned reaction provides an efficient approach to obtaining various cyanoalkyl alkenes, which are synthetically valuable organic skeletons in organic and medicinal chemistry, under mild reaction conditions. The protocol tolerates many critical functional groups and provides a route for the modification of complex organic molecules.

Tetracyclic Triterpenoids, Steroids and Lignanes from the Aerial Parts of Oxypetalum caeruleum

Warashina, Tsutomu,Shirota, Osamu

, p. 226 - 231 (2021/02/09)

The MeOH extract from dried aerial parts of Oxypetalum caeruleum (Apocynaceae) plants yielded seventeen compounds, including four new tetracyclic triterpenoids, one pregnane glycoside, two lignane glycosides, and ten known compounds. The structures of the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 530-59-6